Baker Bros. Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $5.38M | Sell |
|
|||||
|
2020
Q4 | $13.4M | Sell |
|
|||||
|
2020
Q3 | $8.98M | Sell |
|
|||||
|
2020
Q2 | $8.96M | Hold |
|
|||||
|
2020
Q1 | $6.37M | Hold |
|
|||||
|
2019
Q4 | $8.37M | Hold |
|
|||||
|
2019
Q3 | $9.05M | Hold |
|
|||||
|
2019
Q2 | $10.8M | Hold |
|
|||||
|
2019
Q1 | $9.54M | Hold |
|
|||||
|
2018
Q4 | $11.5M | Sell |
|
|||||
|
2018
Q3 | $21.8M | Hold |
|
|||||
|
2018
Q2 | $18.2M | Sell |
|
|||||
|
2018
Q1 | $30.5M | Sell |
|
|||||
|
2017
Q4 | $34.7M | Hold |
|
|||||
|
2017
Q3 | $31.7M | Sell |
|
|||||
|
2017
Q2 | $36.2M | Sell |
|
|||||
|
2017
Q1 | $23.6M | Buy |
|
|||||
|
2016
Q4 | $12.4M | Hold |
|
|||||
|
2016
Q3 | $18.8M | Hold |
|
|||||
|
2016
Q2 | $23.5M | Hold |
|
|||||
|
2016
Q1 | $24.5M | Hold |
|
|||||
|
2015
Q4 | $37M | Buy |
|
|||||
|
2015
Q3 | $21.2M | Buy |
|
|||||
|
2015
Q2 | $35.8M | Buy |
|
|||||
|
2015
Q1 | $22M | Buy |
|
|||||
|
2014
Q4 | $14.5M | Buy |
|
|||||
|
2014
Q3 | $9.33M | Buy |
|
|||||
|
2014
Q2 | $7.98M | Hold |
|
|||||
|
2014
Q1 | $9.45M | Buy |
|
|||||
|
2013
Q4 | $5.89M | Buy |
|
|||||
|
2013
Q3 | $1.85M | Buy |
|